Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 451.5 SEK 1.23% Market Closed
Market Cap: 14.2B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Cash Flow Statement

Cash Flow Statement
Xvivo Perfusion AB

Rotate your device to view
Cash Flow Statement
Currency: SEK
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
9
8
5
5
4
7
9
9
7
3
1
1
2
7
12
16
16
17
12
9
15
5
12
(9)
(34)
(57)
(56)
(48)
(30)
7
5
26
30
22
33
34
32
95
108
129
216
Depreciation & Amortization
0
4
0
0
0
12
0
0
0
13
0
0
0
15
0
0
0
17
0
0
0
25
0
0
0
0
0
0
0
0
0
0
0
42
0
0
0
76
0
0
0
Other Non-Cash Items
2
(0)
6
9
11
(0)
13
12
13
1
14
15
14
(2)
13
16
17
(1)
16
16
19
4
26
38
39
49
47
40
35
7
15
9
8
(15)
26
29
46
(78)
1
20
(46)
Cash Taxes Paid
4
5
3
3
3
3
6
4
5
5
3
5
5
3
2
(1)
(2)
(1)
(0)
2
2
3
3
2
1
(0)
(1)
1
1
3
3
2
2
(0)
0
0
2
7
7
10
11
Change in Working Capital
(3)
(16)
(18)
(13)
(16)
(10)
(2)
(2)
1
(5)
(10)
(10)
(8)
2
8
5
1
(10)
(14)
(3)
0
(4)
(0)
(9)
(3)
(4)
(2)
(19)
(39)
(26)
(52)
(54)
(33)
(22)
(34)
(21)
(28)
(46)
(49)
(80)
(103)
Cash from Operating Activities
9
N/A
(5)
N/A
(7)
-56%
1
N/A
(1)
N/A
9
N/A
20
+131%
19
-4%
22
+13%
13
-42%
5
-58%
6
+13%
8
+38%
22
+173%
33
+50%
38
+13%
34
-10%
24
-30%
15
-38%
23
+54%
34
+53%
30
-14%
39
+31%
20
-48%
3
-87%
(12)
N/A
(11)
+9%
(27)
-141%
(33)
-24%
(12)
+64%
(32)
-163%
(20)
+37%
6
N/A
28
+406%
25
-11%
42
+70%
50
+19%
46
-7%
60
+30%
69
+15%
67
-3%
Investing Cash Flow
Capital Expenditures
0
(15)
0
0
0
(13)
0
0
0
(21)
0
0
0
(35)
0
0
0
(55)
0
0
0
(84)
0
0
0
(65)
0
0
0
(94)
0
0
0
(131)
0
0
0
(144)
0
0
0
Other Items
(20)
(0)
(15)
(15)
(12)
(1)
(15)
(19)
(25)
(9)
(32)
(30)
(31)
(1)
(40)
(53)
(55)
2
(54)
(63)
(69)
(0)
(88)
(74)
(71)
(202)
(270)
(279)
(285)
(94)
(221)
(232)
(246)
(67)
(179)
(192)
(186)
(18)
(171)
(172)
(185)
Cash from Investing Activities
(20)
N/A
(15)
+25%
(15)
+5%
(15)
-2%
(12)
+21%
(14)
-22%
(15)
-5%
(19)
-27%
(25)
-30%
(30)
-21%
(32)
-9%
(30)
+8%
(31)
-6%
(36)
-13%
(40)
-13%
(53)
-32%
(55)
-4%
(53)
+3%
(54)
-1%
(63)
-16%
(69)
-11%
(84)
-21%
(88)
-5%
(74)
+16%
(71)
+5%
(267)
-277%
(270)
-1%
(279)
-3%
(285)
-2%
(188)
+34%
(221)
-18%
(232)
-5%
(246)
-6%
(198)
+20%
(179)
+10%
(192)
-7%
(186)
+3%
(162)
+13%
(171)
-6%
(172)
-1%
(185)
-8%
Financing Cash Flow
Net Issuance of Common Stock
63
70
0
0
0
(1)
0
0
0
0
0
0
0
185
0
0
0
19
0
0
0
29
0
0
0
488
0
0
0
245
0
0
0
0
0
0
0
429
0
0
0
Net Issuance of Debt
0
(7)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3)
0
0
0
(6)
0
0
0
(11)
0
0
0
(7)
0
0
0
(11)
0
0
0
Other
0
0
64
62
62
0
(1)
0
0
0
0
185
185
0
185
19
19
0
18
27
26
0
25
(3)
484
0
483
483
(4)
0
234
233
233
0
(7)
(10)
419
419
419
418
(12)
Cash from Financing Activities
63
N/A
64
+0%
58
-8%
53
-10%
(1)
N/A
(1)
-133%
(1)
0%
0
N/A
0
N/A
0
+2%
0
-2%
185
+76 908%
185
0%
185
+0%
185
+0%
19
-90%
19
0%
19
0%
18
-4%
27
+46%
26
-3%
26
-3%
25
-3%
(3)
N/A
484
N/A
483
0%
483
+0%
483
+0%
(4)
N/A
235
N/A
234
0%
233
0%
233
0%
(7)
N/A
(7)
-9%
(10)
-31%
419
N/A
419
0%
419
+0%
418
0%
(12)
N/A
Change in Cash
Effect of Foreign Exchange Rates
0
0
1
1
1
0
(0)
(0)
0
1
1
0
(1)
(1)
(1)
2
2
2
4
2
5
2
7
(1)
(5)
(10)
(10)
(6)
(2)
10
8
25
37
24
20
13
(4)
(4)
5
(6)
(14)
Net Change in Cash
52
N/A
44
-15%
38
-15%
39
+4%
(12)
N/A
(7)
+44%
3
N/A
0
-95%
(3)
N/A
(16)
-542%
(26)
-60%
161
N/A
161
0%
170
+6%
177
+4%
6
-97%
0
-93%
(8)
N/A
(17)
-106%
(11)
+36%
(4)
+67%
(27)
-654%
(18)
+34%
(58)
-226%
411
N/A
194
-53%
192
-1%
171
-11%
(324)
N/A
44
N/A
(11)
N/A
6
N/A
30
+365%
(152)
N/A
(142)
+7%
(146)
-3%
280
N/A
300
+7%
313
+5%
309
-1%
(144)
N/A
Free Cash Flow
Free Cash Flow
9
N/A
(20)
N/A
(7)
+63%
1
N/A
(1)
N/A
(5)
-647%
20
N/A
19
-4%
22
+13%
(8)
N/A
5
N/A
6
+13%
8
+38%
(13)
N/A
33
N/A
38
+13%
34
-10%
(31)
N/A
15
N/A
23
+54%
34
+53%
(54)
N/A
39
N/A
20
-48%
3
-87%
(77)
N/A
(11)
+85%
(27)
-141%
(33)
-24%
(106)
-217%
(32)
+70%
(20)
+37%
6
N/A
(103)
N/A
25
N/A
42
+70%
50
+19%
(98)
N/A
60
N/A
69
+15%
67
-3%

See Also

Discover More